Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001. What Are Smart Beta ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund ...

Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to ...

BBH offers lower costs and concentrated large-cap exposure, while PBE delivers higher dividend income and slightly better ...

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the ...

One of the bellwethers for the industry, the iShares Biotechnology ETF ($IBB) (left chart), has gained over 24% year to date. Another ETF, the State Vanguard S&P 500 ETF ($VOO) remains one of the most ...

Virtus Biotech ETF is rated a buy for its focused exposure to FDA-approved biotech firms and strong recent outperformance. BBP’s equal-weight, quarterly rebalancing strategy efficiently captures ...

Many of the pharmaceutical stocks I've covered witnessed a recent slump since the beginning of January 2016. I look for ways to offset this loss. ProShares UltraShort Nasdaq Biotechnology offers such ...

A 100% tariff on imported drugs just expanded to cover every drugmaker in the country, yet the biotech market's most closely watched fund treated it like a non-event. The reason says everything about ...

Investors weighing Invesco S&P 500 Equal Weight Health Care ETF(NYSEMKT:RSPH) against Invesco Nasdaq Biotechnology ETF(NASDAQ:IBBQ) must choose between a broad, equal-weighted healthcare mandate and a ...